✦ LIBER ✦
China's Hubei Biocause to build crude C4 to C3 olefin conversion plant
- Publisher
- Elsevier Science
- Year
- 2011
- Weight
- 47 KB
- Volume
- 2011
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
✦ Synopsis
Biocause Pharmaceutical plans to construct an olefins conversion unit (OCU) in Jingmen, central Hubei province, at a cost of Yuan 302 M ($45.4 M). The 200,000 tonne/y plant will produce propylene using the process of catalytic cracking of crude C 4 .